Case Studies

Conferences provide an important opportunity to engage with multiple stakeholders as large groups or in smaller 1:1 settings.  IP leveraged its expertise to coordinate multiple types of engagements and gather key insights for its client.

In order to develop an engagement plan for a stakeholder community which was growing and complex, IP identified and engaged multiple tiers of opinion leaders ensuring the client was able to reach a broad customer audience.

A ground-breaking medical device, although recognized by major clinical compendia, was lacking the appropriate Current Procedural Terminology (CPT) codes. This created hesitancy among providers, who feared they would not be reimbursed or prescribing this supportive care technology for their patients.

To ensure broad access for their supportive care technology, a European-based medical device company looking to enter the US market sought guidance and support in understanding the US payer system and how to gain buy-in from US healthcare providers.

A clinical-stage pharmaceutical company faced a unique barrier in bringing its first product to market—seeking pan-tumor approval based on a genetic marker, rather than a traditional approval based on cancer type. They subsequently sought recognition for the product across relevant clinical compendia.